All News #Library
Sciences
VistaGen - Nanocap CNS Drug Chasing Ketamine Fame
21 May 2018 //
SEEKING ALPHA
VistaGen Therapeutics Initiates Phase 2 Study of AV-101 for Major Depressive Disorder
05 Apr 2018 //
PRESS RELEASE

Market Place
Sourcing Support